U.S. Markets closed

Cramer's lightning round: This energy play should do well even with low oil prices

Elizabeth Gurdus
CNBC. Jim Cramer zoomed through his take on callers' favorite stocks, including a bedraggled energy stock.

It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:

Halliburton (NYSE: HAL): "I like Halliburton's analyst data. They were good. My charitable trust owns Schlumberger (NYSE: SLB). I think that's even better."

Noble Energy Inc. (NYSE: NBL): "Noble's good. Noble's good. It's a very well-run, very conservative company. [It] should do well in this environment with oil down in the mid-$40s. It will make money. It's starting to turn up right here."

Himax Technologies (NASDAQ: HIMX): "Look, that area is so red-hot. You saw the Exar deal today. It's a Taiwanese company. I say it's fine. I'm not going to jump up and down. I actually think Cypress (NASDAQ: CY) is better right here, CY. Yes, Cypress Semi[conductors], remember them? They're going to be in the Apple iPhone, it looks like."

Chemours Co. (NYSE: CC): "The spin-off, it did it without me. I was worried about the environmental concerns, didn't opine on it, [and] this thing is on fire. I've got to tell you, Chemours may not be done going higher. There's so many people short the darn thing."

Zoetis Inc. (NYSE: ZTS): "Look, I think it's animal health, but more important, it's got humanization of pets to it. Anyone see Idex Labs lately? Holy cow."

Golden Ocean Group Ltd. (NASDAQ: GOGL): "Look, the bullet freight is up, it's a huge amount of bulk shipping, though, [that] I don't like. I'm going to have to say don't buy."

Alcoa (NYSE: AA): "I like Alcoa as a commodity play, given that the Baltic freight keeps hitting new highs and given the fact that Alcoa has taken a lot of cost out. I'm a buyer down here at $32. It did go up to the mid-30s, started in the 20s, I still like it."

Celgene Corp. (NASDAQ: CELG): "Celgene's a buy. No, it's terrific. And I've got to tell you, I thought Regeneron (NASDAQ: REGN) should have gone up more on that atopic dermatitis."

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com



More From CNBC